WO1996011267A1 - Dna coding for a zinc finger protein, a zinc finger protein and the use thereof - Google Patents

Dna coding for a zinc finger protein, a zinc finger protein and the use thereof Download PDF

Info

Publication number
WO1996011267A1
WO1996011267A1 PCT/DE1995/001390 DE9501390W WO9611267A1 WO 1996011267 A1 WO1996011267 A1 WO 1996011267A1 DE 9501390 W DE9501390 W DE 9501390W WO 9611267 A1 WO9611267 A1 WO 9611267A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
zinc finger
protein
finger protein
nucleotides
Prior art date
Application number
PCT/DE1995/001390
Other languages
German (de)
French (fr)
Inventor
Elisabeth Schwarz
Matthias Bartelmann
Marie-Stella Reuter
Original Assignee
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts filed Critical Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Priority to JP8512260A priority Critical patent/JPH10506789A/en
Priority to EP95935327A priority patent/EP0784680A1/en
Publication of WO1996011267A1 publication Critical patent/WO1996011267A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Definitions

  • Zinc finger DNA, protein and their use relates to a DNA coding for a zinc finger protein and such a protein.
  • the invention further relates to the use of the DNA and the protein.
  • the conversion of normal cells into tumor cells takes place in several steps, which involve changes in cellular genes or the acquisition of viral oncogenes. Changes in cellular genes include the activation of proto-oncogenes by mutation, gene amplification, overexpression or chromosome translocations as well as the inactivation of tumor suppressor genes by mutation or deletion.
  • genes the changes of which are important in the development of tumors, have so far been identified (cf. review article: Bishop, J.M., Cell 64 (1 991), 235-248).
  • the products of such genes have different functions. They work e.g. as transcription regulators, as links in different signal transduction chains, such as growth factors, growth factor receptors or protein kinases, or as activators or inhibitors of cell division.
  • transcription regulators are zinc finger proteins. These proteins have characteristic structures containing two cysteine and two histidine residues which are positioned relative to one another in such a way that they bind a zinc atom. Zinc finger proteins are DNA-binding proteins. An example of zinc finger proteins is the product of the Wilms tumor suppressor gene WT1, the loss of which plays an important role in the development of Wilms kidney tumors.
  • the present invention is therefore based on the object of providing a means with which tumor diagnosis and therapy can be carried out more comprehensively.
  • the invention thus relates to a DNA coding for a zinc finger protein, which comprises:
  • hybridizing DNA indicates a DNA which hybridizes with a DNA of (a) under customary conditions, in particular at 20 ° C. below the melting point of the DNA.
  • FIG. 1 shows the insert of the cDNA clone COS AP4-E1.
  • This clone comes from a cDNA library of the cervical carcinoma cell line ME 180 (cf. Reuter, M.S. et al., J. Virol. 65 (1991), 5564-5568).
  • This cell line contains the human papillomavirus 68-DNA (HPV 68-DNA) stably integrated.
  • the clone COS AP4-E1 contains HPV 68 DNA between nucleotides 1-21. It also contains cellular sequences between nucleotides 22-1476, these being exon sequences of a zinc finger gene between nucleotides 446-1476.
  • the exon sequences code for 4 zinc fingers zinc finger 1: 1130-1 191, zinc finger 2: 1214-1275, zinc finger 3: 1298-1360, zinc finger 4: 1382-1432.
  • the clone COS AP4-E1 was deposited with the DSM (German Collection of Microorganisms and Cell Cultures under DSM 9450 on September 30, 1994).
  • the above insert DNA can be part of a DNA coding for a complete zinc finger protein.
  • Such a DNA and the zinc finger protein encoded by it are thus also the subject of the invention.
  • the insert DNA from COS AP4-E1 in particular the DNA between nucleotides 446-1476
  • a cDNA library from blood cells or HeLa cells can also be used.
  • the tissues and cells mentioned contain sufficient RNA transcripts that hybridize with the insert DNA from COS AP4-E1, in particular the DNA between nucleotides 446-1476 (cf. FIG. 2). Clones obtained are subjected to sequencing and, starting from the insert DNA of COS AP4-E1, in particular the DNA between nucleotides 446-1476, the DNA coding for a zinc finger protein above is determined.
  • the insert DNA from COS AP4-E1 in particular the DNA between nucleotides 446-1476, and very particularly the DNA between nucleotides 1240-1476, is suitable for identifying a genomic DNA coding for the above zinc finger protein.
  • the corresponding DNA from COS AP4-E1 e.g. the DNA between the nucleotides 1240-1476, used as a probe for hybridizing a genomic DNA library.
  • Such can be created from the tissues and cells mentioned above.
  • the clone COS 1 APM is obtained. Its insert DNA contains in a 5.5 kb Sacl fragment the probe used, e.g. DNA corresponding to DNA between nucleotides 1240-1476. In Figures 3 and 4 this DNA from COS 1 APM is presented between nucleotides 256-492.
  • the clone COS 1 APM was deposited with the DSM under DSM 9462 on October 7, 1994. The invention thus also relates to a genomic DNA encoding the above zinc finger protein and the protein encoded by it.
  • the DNA coding for the zinc finger protein can be present in a vector or expression vector.
  • a vector or expression vector examples of such are known to the person skilled in the art.
  • these are, for example, pGE-MEX, pUC derivatives and pGEX-2T.
  • yeast for example, pY100 and Ycpadl should be mentioned, while for expression in animal cells, for example, pKCR, pEF- BOS, cDM8 and pCEV4 must be specified.
  • suitable cells in order to express the above DNA present in an expression vector examples of such cells include the E.
  • the person skilled in the art knows how the above DNA has to be inserted into an expression vector. He is also aware that the above cDNA can be expressed in E. coli, yeast or animal cells, whereas the above genomic DNA is only to be expressed in animal cells. Furthermore, the person skilled in the art knows the conditions for cultivating transformed or transfected cells. He is also familiar with methods of isolating and purifying the expressed zinc finger protein. An above, recombinantly produced zinc finger protein is therefore also the subject of the invention.
  • Another object of the invention is an antibody directed against an above zinc finger protein.
  • Such is produced in the usual way.
  • the zinc finger protein is injected subcutaneously into BALB / c mice. This injection is repeated every 3 weeks. About 2 weeks after the last injection, the serum containing the antibody is isolated and tested in the usual way.
  • the antibody is a monoclonal antibody.
  • spleen cells are removed from the mice after the fourth injection above and these are fused with myeloma cells in the usual way. The further cloning is also carried out according to known methods.
  • the present invention provides a previously unknown zinc finger DNA and a zinc finger protein encoded by it.
  • the DNA according to the invention is suitable as a probe for diagnostic purposes.
  • it can be used for gene therapy in an expression vector known to those skilled in the art.
  • the protein according to the invention is also suitable for therapeutic purposes. For this purpose, it can be administered in a customary pharmaceutical composition.
  • the present invention further provides antibodies directed against the above protein. These are ideal for diagnostic purposes.
  • the present invention thus provides new means for the diagnosis and therapy of diseases related to the DNA according to the invention and the protein encoded by them, in particular tumor diseases.
  • FIG. 2 shows the hybridization of polyA + RNA from different cells with the DNA between nucleotides 1240-1476 of COS AP4-E1
  • FIG. 3 shows a partial sequence of the genomic insert DNA of the clone COS 1
  • FIG. 4 shows the comparison of the DNA between nucleotides 1240-1476 of clone COS AP4-E1 and the DNA between nucleotides 256-
  • the invention is illustrated by the following example.
  • a ⁇ cDNA library created from HeLa cells is subjected to a conventional hybridization process.
  • the phage plaques obtained by infection of the bacteria are incubated with the 32 p-labeled DNA insert of the clone COS AP4-E1, in particular the DNA between the nucleotides 1240-1476 (cf. FIG. 1). Hybridization with individual phage plaques is obtained.
  • the phage DNA is isolated from these and cleaved with EcoRI.
  • the fragments obtained are separated electrophoretically in a 0.5% agarose gel.
  • the agarose gel is subjected to a conventional blotting process, whereby the DNA from the agarose gel is transferred to a nitrocellulose membrane.

Abstract

The invention concerns DNA coding for a zinc finger protein and a protein of this type. The invention further concerns the use of the DNA and the protein in diagnosis, therapy or gene therapy of tumors. The DNA coding for the zinc finger protein is an insert of the cDNA clone COS AP4-E1. This clone comes from a cDNA library of the cervix carcinoma cell line ME180, which contains the human papilloma virus 68 DNA, and has four zinc fingers in its exon sequences.

Description

Zinkf inqer-DNA, -Protein und ihre Verwendung Die Erfindung betrifft eine für ein Zinkfinger-Protein codierende DNA und ein solches Protein. Ferner betrifft die Erfindung die Verwendung der DNA und des Proteins. Zinc finger DNA, protein and their use The invention relates to a DNA coding for a zinc finger protein and such a protein. The invention further relates to the use of the DNA and the protein.
Die Umwandlung von normalen Zellen in Tumorzellen vollzieht sich in mehreren Teilschritten, bei denen es zu Veränderungen zellulärer Gene oder zum Erwerb viraler Onkogene kommt. Veränderungen zellulärer Gene umfassen die Aktivierung von Proto-Onkogenen durch Mutation, Genamplifikation, Überexpression oder Chromosomen-Translokationen sowie die Inaktivierung von Tumorsuppressorgenen durch Mutation oder Deletion.The conversion of normal cells into tumor cells takes place in several steps, which involve changes in cellular genes or the acquisition of viral oncogenes. Changes in cellular genes include the activation of proto-oncogenes by mutation, gene amplification, overexpression or chromosome translocations as well as the inactivation of tumor suppressor genes by mutation or deletion.
Verschiedene Gene, deren Veränderungen bei der Tumorentstehung von Bedeu¬ tung sind, konnten bislang identifiziert werden (vgl. Übersichtsartikel: Bishop, J.M., Cell 64 ( 1 991 ), 235-248). Die Produkte solcher Gene haben verschiedene Funktionen. Sie wirken z.B. als Transkriptionsregulatoren, als Glieder unterschiedli¬ cher Signaltransduktionsketten, wie Wachstumsfaktoren, Wachstumsfaktorrezep¬ toren oder Proteinkinasen, bzw. als Aktivatoren oder Inhibitoren der Zellteilung.Various genes, the changes of which are important in the development of tumors, have so far been identified (cf. review article: Bishop, J.M., Cell 64 (1 991), 235-248). The products of such genes have different functions. They work e.g. as transcription regulators, as links in different signal transduction chains, such as growth factors, growth factor receptors or protein kinases, or as activators or inhibitors of cell division.
Beispiele von Transkriptionsregulatoren sind Zinkfinger-Proteine. Diese Proteine besitzen charakteristische, zwei Cystein- und zwei Histidinreste enthaltende Strukturen, die so zueinander positioniert sind, daß sie ein Zinkatom binden. Zinkfinger-Proteine sind DNA-bindende Proteine. Ein Beispiel für Zinkfinger-Proteine ist das Produkt des Wilms-Tumorsuppressorgen WT1 , dessen Verlust bei der Entstehung von Wilms-Nierentumoren eine wesentliche Rolle spielt.Examples of transcription regulators are zinc finger proteins. These proteins have characteristic structures containing two cysteine and two histidine residues which are positioned relative to one another in such a way that they bind a zinc atom. Zinc finger proteins are DNA-binding proteins. An example of zinc finger proteins is the product of the Wilms tumor suppressor gene WT1, the loss of which plays an important role in the development of Wilms kidney tumors.
Bis heute sind noch nicht alle an Tumorentstehung und -Wachstum beteiligten Gene bzw. Genprodukte bekannt. Eine Tumordiagnose bzw. -therapie ist daher bisher nur begrenzt möglich.To date, not all genes or gene products involved in tumor development and growth are known. Tumor diagnosis and therapy has therefore only been possible to a limited extent.
Der vorliegenden Erfindung liegt somit die Aufgabe zugrunde, ein Mittel bereitzu¬ stellen, mit dem Tumordiagnose bzw. -therapie umfassender betrieben werden kann.The present invention is therefore based on the object of providing a means with which tumor diagnosis and therapy can be carried out more comprehensively.
ERSÄTZBLAT Erfindungsgemäß wird dies durch die Gegenstände in den Patentansprüchen erreicht.REPLACEMENT BLADE According to the invention, this is achieved by the subject matter in the claims.
Gegenstand der Erfindung ist somit eine für ein Zinkfinger-Protein codierende DNA, die umfaßt:The invention thus relates to a DNA coding for a zinc finger protein, which comprises:
(a) die DNA der Nukleotide 446-1476 von Fig. 1 oder einen Teil davon,(a) the DNA of nucleotides 446-1476 of FIG. 1 or a part thereof,
(b) eine mit der DNA von (a) hybridisierende DNA, oder(b) a DNA hybridizing with the DNA of (a), or
(c) eine mit der DNA von (a) oder (b) über den degenerierten genetischen Code verwandte DNA.(c) a DNA related to the DNA of (a) or (b) via the degenerate genetic code.
Der Ausdruck "hybridisierende DNA" weist auf eine DNA hin, die unter üblichen Bedingungen, insbesondere bei 20°C unter dem Schmelzpunkt der DNA, mit einer DNA von (a) hybridisiert.The term "hybridizing DNA" indicates a DNA which hybridizes with a DNA of (a) under customary conditions, in particular at 20 ° C. below the melting point of the DNA.
Fig. 1 zeigt das Insert des cDNA Klons COS AP4-E1. Dieser Klon entstammt einer cDNA-Bibliothek der Cervixcarcinomzellinie ME 180 (vgl. Reuter, M.S. et al., J. Virol. 65 (1991 ), 5564-5568). Diese Zellinie enthält die Human Papillomvirus 68- DNA (HPV 68-DNA) stabil integriert. Der Klon COS AP4-E1 enthält zwischen den Nukleotiden 1-21 HPV 68-DNA. Ferner enthält er zwischen den Nukleotiden 22- 1476 zelluläre Sequenzen, wobei diese zwischen den Nukleotiden 446-1476 Exon- Sequenzen eines Zinkfinger-Gens sind. Die Exon-Sequenzen codieren für 4 Zinkfin¬ ger: Zinkfinger 1 :1130-1 191 , Zinkfinger 2: 1214-1275, Zinkfinger 3: 1298-1360, Zinkfinger 4: 1382-1432. Der Klon COS AP4-E1 wurde bei der DSM (Deutsche Sammlung von Mikroorganismen und Zellkulturen unter DSM 9450 am 30. Sep¬ tember 1994 hinterlegt.1 shows the insert of the cDNA clone COS AP4-E1. This clone comes from a cDNA library of the cervical carcinoma cell line ME 180 (cf. Reuter, M.S. et al., J. Virol. 65 (1991), 5564-5568). This cell line contains the human papillomavirus 68-DNA (HPV 68-DNA) stably integrated. The clone COS AP4-E1 contains HPV 68 DNA between nucleotides 1-21. It also contains cellular sequences between nucleotides 22-1476, these being exon sequences of a zinc finger gene between nucleotides 446-1476. The exon sequences code for 4 zinc fingers: zinc finger 1: 1130-1 191, zinc finger 2: 1214-1275, zinc finger 3: 1298-1360, zinc finger 4: 1382-1432. The clone COS AP4-E1 was deposited with the DSM (German Collection of Microorganisms and Cell Cultures under DSM 9450 on September 30, 1994).
Vorstehende Insert-DNA, insbesondere zwischen den Nukleotiden 446-1476, kann Teil einer für ein vollständiges Zinkfinger-Protein codierenden DNA sein. Eine solche DNA und das durch sie codierte Zinkfinger-Protein sind somit auch Gegen¬ stand der Erfindung.The above insert DNA, especially between nucleotides 446-1476, can be part of a DNA coding for a complete zinc finger protein. Such a DNA and the zinc finger protein encoded by it are thus also the subject of the invention.
Die Bereitstellung einer für vorstehendes Zinkfinger-Protein codierenden DNA erfolgt in üblicher Weise. Beispielhaft wird die Insert-DNA von COS AP4-E1 , insbesondere die DNA zwischen den Nukleotiden 446-1476, als Sonde zur Hybri¬ disierung einer allgemein erhältlichen cDNA-Bibliothek aus Leber, Gehirn, Plazenta oder Muskel, vorzugsweise Leber, verwendet. Auch kann eine cDNA-Bibliothek aus Blutzellen oder HeLa-Zellen verwendet werden. Die genannten Gewebe und Zellen enthalten ausreichend RNA-Transkripte, die mit der Insert-DNA von COS AP4-E1 , insbesondere der DNA zwischen den Nukleotiden 446-1476 hybridisieren (vgl. Fig. 2). Erhaltene Klone werden einer Sequenzierung unterzogen und ausgehend von der Insert-DNA von COS AP4-E1 , insbesondere der DNA zwischen den Nukleotiden 446-1476, wird die ein vorstehendes Zinkfinger-Protein codierende DNA bestimmt.The provision of a DNA encoding the above zinc finger protein takes place in the usual way. For example, the insert DNA from COS AP4-E1, in particular the DNA between nucleotides 446-1476, is used as a probe for hybridizing a generally available cDNA library from the liver, brain, placenta or muscle, preferably liver. A cDNA library from blood cells or HeLa cells can also be used. The tissues and cells mentioned contain sufficient RNA transcripts that hybridize with the insert DNA from COS AP4-E1, in particular the DNA between nucleotides 446-1476 (cf. FIG. 2). Clones obtained are subjected to sequencing and, starting from the insert DNA of COS AP4-E1, in particular the DNA between nucleotides 446-1476, the DNA coding for a zinc finger protein above is determined.
Des weiteren eignet sich die Insert-DNA von COS AP4-E1 , insbesondere die DNA zwischen den Nukleotiden 446-1476, und ganz besonders die DNA zwischen den Nukleotiden 1240-1476, zur Identifizierung einer genomischen für vorstehendes Zinkfinger-Protein codierenden DNA. Hierzu wird die entsprechende DNA von COS AP4-E1 , z.B. die DNA zwischen den Nukleotiden 1240-1476, als Sonde zur Hybri¬ disierung einer genomischen DNA-Bibliothek verwendet. Eine solche kann aus den vorstehend genannten Geweben und Zellen erstellt sein.Furthermore, the insert DNA from COS AP4-E1, in particular the DNA between nucleotides 446-1476, and very particularly the DNA between nucleotides 1240-1476, is suitable for identifying a genomic DNA coding for the above zinc finger protein. For this, the corresponding DNA from COS AP4-E1, e.g. the DNA between the nucleotides 1240-1476, used as a probe for hybridizing a genomic DNA library. Such can be created from the tissues and cells mentioned above.
Erfindungsgemäß wird der Klon COS 1 APM erhalten. Seine Insert-DNA enthält in einem 5,5 kb großen Sacl-Fragment die zur verwendeten Sonde, z.B. der DNA zwischen den Nukleotiden 1240-1476, entsprechende DNA. In den Figuren 3 und 4 ist diese DNA von COS 1 APM zwischen den Nukleotiden 256-492 präsentiert. Der Klon COS 1 APM wurde bei der DSM unter DSM 9462 am 07.10.1994 hinter¬ legt. Gegenstand der Erfindung ist somit auch eine genomische, das vorstehende Zinkfinger-Protein codierende DNA sowie das durch sie codierte Protein.According to the invention, the clone COS 1 APM is obtained. Its insert DNA contains in a 5.5 kb Sacl fragment the probe used, e.g. DNA corresponding to DNA between nucleotides 1240-1476. In Figures 3 and 4 this DNA from COS 1 APM is presented between nucleotides 256-492. The clone COS 1 APM was deposited with the DSM under DSM 9462 on October 7, 1994. The invention thus also relates to a genomic DNA encoding the above zinc finger protein and the protein encoded by it.
Erfindungsgemäß kann vorstehende für das Zinkfinger-Protein codierende DNA in einem Vektor bzw. Expressionsvektor vorliegen. Beispiele solcher sind dem Fach¬ mann bekannt. Im Falle eines Expressionsvektors für E. coli sind dies z.B. pGE- MEX, pUC-Derivate und pGEX-2T. Für die Expression in Hefe sind z.B. pY100 und Ycpadl zu nennen, während für die Expression in tierischen Zellen z.B. pKCR, pEF- BOS, cDM8 und pCEV4, anzugeben sind. Der Fachmann kennt geeignete Zellen, um vorstehende, in einem Expressionsvektor vorliegende DNA zu exprimieren. Beispiele solcher Zellen umfassen die E.coli-Stämme HB101 , DH1 , x1776, JM101 und JM 109, den Hefe-Stamm Saccharomyces cerevisiae und die tierischen Zellen L, 3T3, FM3A, CHO, COS, Vero, und HeLa. Der Fachmann weiß, in welcher Weise vorstehende DNA in einen Expressionsvektor inseriert werden muß. Ihm ist auch bekannt, daß vorstehende cDNA in E.coli, Hefe oder tierischen Zellen exprimiert werden kann, während vorstehende genomische DNA nur in tierischen Zellen zu exprimieren ist. Des weiteren kennt der Fachmann Bedingungen, transformierte bzw. transfizierte Zellen zu kultivieren. Auch sind ihm Verfahren bekannt, das exprimierte Zinkfinger-Protein zu isolieren und zu reinigen. Ein vorstehendes, rekombinant hergestelltes Zinkfinger-Protein ist somit auch Gegenstand der Erfin¬ dung.According to the invention, the DNA coding for the zinc finger protein can be present in a vector or expression vector. Examples of such are known to the person skilled in the art. In the case of an expression vector for E. coli, these are, for example, pGE-MEX, pUC derivatives and pGEX-2T. For expression in yeast, for example, pY100 and Ycpadl should be mentioned, while for expression in animal cells, for example, pKCR, pEF- BOS, cDM8 and pCEV4 must be specified. The person skilled in the art knows suitable cells in order to express the above DNA present in an expression vector. Examples of such cells include the E. coli strains HB101, DH1, x1776, JM101 and JM 109, the yeast strain Saccharomyces cerevisiae and the animal cells L, 3T3, FM3A, CHO, COS, Vero, and HeLa. The person skilled in the art knows how the above DNA has to be inserted into an expression vector. He is also aware that the above cDNA can be expressed in E. coli, yeast or animal cells, whereas the above genomic DNA is only to be expressed in animal cells. Furthermore, the person skilled in the art knows the conditions for cultivating transformed or transfected cells. He is also familiar with methods of isolating and purifying the expressed zinc finger protein. An above, recombinantly produced zinc finger protein is therefore also the subject of the invention.
Ein weiterer Gegenstand der Erfindung ist ein gegen ein vorstehendes Zinkfinger- Protein gerichteter Antikörper. Die Herstellung eines solchen erfolgt in üblicher Weise. Beispielsweise wird hierzu das Zinkfinger-Protein in BALB/c-Mäuse sub- cutan injiziert. Diese Injektion wird im Abstand von jeweils 3 Wochen wiederholt. Etwa 2 Wochen nach der letzten Injektion wird das den Antikörper enthaltende Serum isoliert und in üblicher Weise getestet.Another object of the invention is an antibody directed against an above zinc finger protein. Such is produced in the usual way. For example, the zinc finger protein is injected subcutaneously into BALB / c mice. This injection is repeated every 3 weeks. About 2 weeks after the last injection, the serum containing the antibody is isolated and tested in the usual way.
In bevorzugter Ausführungsform ist der Antikörper ein monoklonaler Antikörper. Zu seiner Herstellung werden nach vorstehender vierten Injektion den Mäusen Milzzel¬ len entnommen und diese in üblicher Weise mit Myelomzellen fusioniert. Die weitere Klonierung erfolgt ebenso nach bekannten Verfahren.In a preferred embodiment, the antibody is a monoclonal antibody. To produce it, spleen cells are removed from the mice after the fourth injection above and these are fused with myeloma cells in the usual way. The further cloning is also carried out according to known methods.
Die vorliegende Erfindung stellt eine bisher nicht gekannte Zinkfinger-DNA sowie ein durch sie codiertes Zinkfinger-Protein bereit. Die erfindungsgemäße DNA eignet sich als Sonde für diagnostische Zwecke. Darüberhinaus kann sie in einem dem Fachmann bekannten Expressionsvektor zur Gentherapie eingesetzt werden. Das erfindungsgemäße Protein eignet sich ebenfalls für therapeutische Zwecke. Hierzu kann es in einer üblichen pharmazeutischen Zusammensetzung verabreicht werden. Des weiteren stellt die vorliegende Erfindung gegen das vorstehende Protein gerichtete Antikörper bereit. Diese eignen sich bestens zu diagnostischen Zwek- ken.The present invention provides a previously unknown zinc finger DNA and a zinc finger protein encoded by it. The DNA according to the invention is suitable as a probe for diagnostic purposes. In addition, it can be used for gene therapy in an expression vector known to those skilled in the art. The protein according to the invention is also suitable for therapeutic purposes. For this purpose, it can be administered in a customary pharmaceutical composition. The present invention further provides antibodies directed against the above protein. These are ideal for diagnostic purposes.
Somit liefert die vorliegende Erfindung neue Mittel zur Diagnose und Therapie von mit der erfindungsgemäßen DNA und dem durch sie codierten Protein zusammen¬ hängenden Erkrankungen, insbesondere von Tumorerkrankungen.The present invention thus provides new means for the diagnosis and therapy of diseases related to the DNA according to the invention and the protein encoded by them, in particular tumor diseases.
Kurze Beschreibung der Zeichnung:Brief description of the drawing:
Fig. 1 zeigt die Insert-cDNA des Klons COS AP4-E1 ,1 shows the insert cDNA of the clone COS AP4-E1,
Fig. 2 zeigt die Hybridisierung von PolyA+RNA aus verschiedenen Zellen mit der DNA zwischen den Nukleotiden 1240-1476 von COS AP4-E1 , Fig. 3 zeigt eine Teilsequenz der genomischen Insert-DNA des Klons COS 1FIG. 2 shows the hybridization of polyA + RNA from different cells with the DNA between nucleotides 1240-1476 of COS AP4-E1, FIG. 3 shows a partial sequence of the genomic insert DNA of the clone COS 1
APM, und Fig. 4 zeigt den Vergleich der DNA zwischen den Nukleotiden 1240-1476 von Klon COS AP4-E1 und der DNA zwischen den Nukleotiden 256-APM, and FIG. 4 shows the comparison of the DNA between nucleotides 1240-1476 of clone COS AP4-E1 and the DNA between nucleotides 256-
492 von Klon COS 1 APM.492 from clone COS 1 APM.
Die Erfindung wird durch das folgende Beispiel erläutert.The invention is illustrated by the following example.
Beispiel: Herstellung einer erfindungsgemäßen Zinkfinger-DNAExample: Production of a zinc finger DNA according to the invention
Eine aus HeLa-Zellen erstellte λ cDNA-Bibliothek wird einem üblichen Hybridis- ierungsverfahren unterzogen. Hierzu werden die durch Infektion der Bakterien erhaltenen Phagenplaques mit dem 32p-markierten DNA-Insert des Klons COS AP4- E1 , insbesondere der DNA zwischen den Nukleotiden 1240-1476 (vgl. Fig. 1 ), inkubiert. Es wird eine Hybridisierung mit einzelnen Phagenplaques erhalten. Aus diesen wird die Phagen-DNA isoliert und mit EcoRI gespalten. Die erhaltenen Fragmente werden in einem 0,5%igen Agarosegel elektrophoretisch aufgetrennt. Das Agarosegel wird einem üblichen Blotting-Verfahren unterzogen, wodurch die DNA aus dem Agarosegel auf eine Nitrozellulosemembran übertragen wird. Diese wird in ein Hybridisierungsverfahren eingesetzt, in dem die entsprechende DNA des DNA-Inserts von Klon COS AP4-E1 als 3 p-markierte Probe verwendet wird. Es wird eine Hybridisierung mit einzelnen DNA-Fragmenten erhalten. Diese werden isoliert und in einem mit EcoRI gespaltenen, dephosphorylierten Plasmid-Vektor, z.B. pBluescript, kloniert. Einzelne Klone werden analysiert, und durch Restriktions¬ spaltungen sowie Sequenzierung wird ein eine erfindungsgemäße Zinkfinger-DNA enthaltender Klon identifiziert. A λ cDNA library created from HeLa cells is subjected to a conventional hybridization process. For this purpose, the phage plaques obtained by infection of the bacteria are incubated with the 32 p-labeled DNA insert of the clone COS AP4-E1, in particular the DNA between the nucleotides 1240-1476 (cf. FIG. 1). Hybridization with individual phage plaques is obtained. The phage DNA is isolated from these and cleaved with EcoRI. The fragments obtained are separated electrophoretically in a 0.5% agarose gel. The agarose gel is subjected to a conventional blotting process, whereby the DNA from the agarose gel is transferred to a nitrocellulose membrane. This is used in a hybridization process in which the corresponding DNA of the DNA insert from clone COS AP4-E1 is used as a 3 p-labeled sample. Hybridization with individual DNA fragments is obtained. These are isolated and cloned in a dephosphorylated plasmid vector, for example pBluescript, which has been digested with EcoRI. Individual clones are analyzed, and a clone containing a zinc finger DNA according to the invention is identified by restriction cleavage and sequencing.

Claims

Patentansprüche claims
1. DNA, codierend für ein Zinkfinger-Protein, wobei die DNA umfaßt:1. DNA coding for a zinc finger protein, the DNA comprising:
(a) die DNA der Nukleotide 446 - 1476 von Fig. 1 oder einen Teil davon,(a) the DNA of nucleotides 446-1476 of FIG. 1 or a part thereof,
(b) eine mit der DNA von (a) hybridisierende DNA, oder(b) a DNA hybridizing with the DNA of (a), or
(c) eine mit der DNA von (a) oder (b) über den degenerierten genetischen Code verwandte DNA.(c) a DNA related to the DNA of (a) or (b) via the degenerate genetic code.
2. DNA nach Anspruch 1 , nämlich die DNA der Nukleotide 256 - 492 von Fig. 3.2. DNA according to claim 1, namely the DNA of nucleotides 256-492 of FIG. 3.
3. Protein, codiert durch die DNA nach Anspruch 1 oder 2.3. Protein encoded by the DNA of claim 1 or 2.
4. Expressionsplasmid, umfassend eine für das Protein nach Anspruch 3 codie¬ rende DNA.4. Expression plasmid comprising a DNA coding for the protein according to claim 3.
5. Transformante, enthaltend den Expressionsplasmid nach Anspruch 4.5. Transformant containing the expression plasmid according to claim 4.
6. Verfahren zur Herstellung des Proteins nach Anspruch 3, umfassend die Kultivierung der Transformante nach Anspruch 5 unter geeigneten Bedin¬ gungen.6. A method for producing the protein according to claim 3, comprising culturing the transformant according to claim 5 under suitable conditions.
7. Verwendung der DNA nach Anspruch 1 oder 2 als Reagens zur Diagnose und/oder Therapie.7. Use of the DNA according to claim 1 or 2 as a reagent for diagnosis and / or therapy.
8. Verwendung des Proteins nach Anspruch 3 als Reagens zur Therapie. 8. Use of the protein according to claim 3 as a reagent for therapy.
PCT/DE1995/001390 1994-10-07 1995-10-06 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof WO1996011267A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP8512260A JPH10506789A (en) 1994-10-07 1995-10-06 DNA encoding zinc finger protein, zinc finger protein and uses thereof
EP95935327A EP0784680A1 (en) 1994-10-07 1995-10-06 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4435919.5 1994-10-07
DE4435919A DE4435919C1 (en) 1994-10-07 1994-10-07 DNA encoding zinc finger protein

Publications (1)

Publication Number Publication Date
WO1996011267A1 true WO1996011267A1 (en) 1996-04-18

Family

ID=6530235

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1995/001390 WO1996011267A1 (en) 1994-10-07 1995-10-06 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof

Country Status (4)

Country Link
EP (1) EP0784680A1 (en)
JP (1) JPH10506789A (en)
DE (1) DE4435919C1 (en)
WO (1) WO1996011267A1 (en)

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021991A1 (en) * 1997-10-29 1999-05-06 Shanghai Second Medical University Bmzf12: a zinc finger gene cloned from bone marrow
WO1999046293A1 (en) * 1998-03-12 1999-09-16 Shanghai Second Medical University A zinc finger protein derived from hematopoietic cells
WO2001066582A1 (en) * 2000-03-10 2001-09-13 Shanghai Biowindow Gene Development Inc. A NEW POLYPEPTIDE-HUMAN ZINC FINGER PROTEIN 27 AND THE POLYNUCLEOTIDE ENCODING It
WO2001066583A1 (en) * 2000-03-10 2001-09-13 Shanghai Biowindow Gene Development Inc. A new polypeptide - human zinc finger protein 14 and the polynucleotide encoding it
WO2001066580A1 (en) * 2000-03-07 2001-09-13 Biowindow Gene Development Inc. Shanghai A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it
WO2001068690A1 (en) * 2000-03-15 2001-09-20 Shanghai Biowindow Gene Development Inc. A new polypeptide-human zinc finger protein 15 and the polynucleotide encoding it
WO2001072803A1 (en) * 2000-03-28 2001-10-04 Shanghai Biowindow Gene Development Inc. A new polypeptide- human zinc finger protein 15 and the polynucleotide encoding it
WO2001074866A1 (en) * 2000-03-02 2001-10-11 Biowindow Gene Development Inc. Shanghai A novel polypeptide-human zinc finger protein 72 and the polynucleotide encoding said polypeptide
WO2001074882A1 (en) * 2000-03-28 2001-10-11 Shanghai Biowindow Gene Development Inc. A novel polypeptide-human zinc finger protein 49 and the polynucleotide encoding said polypeptide
WO2001074865A1 (en) * 2000-03-15 2001-10-11 Shanghai Biowindow Gene Development Inc. A novel polypeptide - human zinc finger protein 10 and the polynucleotide encoding said polypeptide
WO2001074868A1 (en) * 2000-03-07 2001-10-11 Biowindow Gene Development Inc. Shanghai A novel polypeptide-human zinc finger protein 10 and the polynucleotide encoding said polypeptide
WO2001074993A2 (en) * 2000-03-10 2001-10-11 Shanghai Biowindow Gene Development Inc. A novel polypeptide - human zinc finger protein 17 and the polynucleotide encoding said polypeptide
WO2001094397A1 (en) * 2000-06-07 2001-12-13 Shanghai Biowindow Gene Development Inc. A novel polypeptide-zinc finger protein 79.46 and the polynucleotide encoding said polypeptide
WO2002004502A1 (en) * 2000-06-19 2002-01-17 Biowindow Gene Development Inc. Shanghai A NEW POLYPEPTIDE- MURINE ZINC FINGER PROTEIN (Zfp-1)16 AND THE POLYNUCLEOTIDE ENCODING IT
WO2002004500A1 (en) * 2000-06-19 2002-01-17 Biowindow Gene Development Inc. Shanghai A new polypeptide- human zinc finger protein fpm315-17 and the polynucleotide encoding it
WO2002010211A1 (en) * 2000-06-30 2002-02-07 Shanghai Biowindow Gene Development Inc. A new polypeptide- human zinc finger protein 12.98 and the polynucloetide encoding it
WO2002020600A1 (en) * 2000-06-28 2002-03-14 Shanghai Biowindow Gene Development Inc. A new polypeptide- human zinc finger protein 10.45 and the polynucleotide encoding it
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6479626B1 (en) 1998-03-02 2002-11-12 Massachusetts Institute Of Technology Poly zinc finger proteins with improved linkers
US6503717B2 (en) 1999-12-06 2003-01-07 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6733970B2 (en) 1998-11-09 2004-05-11 Gendaq Limited Screening system for zinc finger polypeptides for a desired binding ability
US6746838B1 (en) 1997-05-23 2004-06-08 Gendaq Limited Nucleic acid binding proteins
US6790941B2 (en) 1994-01-18 2004-09-14 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US6977154B1 (en) 1998-03-17 2005-12-20 Gendaq Limited Nucleic acid binding proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
USRE39229E1 (en) 1994-08-20 2006-08-08 Gendaq Limited Binding proteins for recognition of DNA
US7262054B2 (en) 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7273923B2 (en) 2001-01-22 2007-09-25 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7361635B2 (en) 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
US7585849B2 (en) 1999-03-24 2009-09-08 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US7851216B2 (en) 2000-01-24 2010-12-14 Gendaq, Ltd. Methods and compositions for linking binding domains in nucleic acid binding proteins

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825198A1 (en) * 1996-08-22 1998-02-25 K.U. Leuven Research & Development Plag gene family and tumorigenesis
WO1999062951A1 (en) * 1998-06-04 1999-12-09 Shanghai Second Medical University A human zinc finger protein gene (bmzf3)
US7473528B2 (en) 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
WO2000040749A2 (en) 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
CN1328040A (en) * 2000-06-12 2001-12-26 上海博德基因开发有限公司 Polypeptide-human zinc finger protein 18.04 and polynucleotide for coding it
CN1331219A (en) * 2000-06-30 2002-01-16 上海博德基因开发有限公司 Polypeptide-human zinc finger protein 18.92 and polynucleotide for coding it
ES2387546T3 (en) 2001-05-11 2012-09-25 Amgen Inc. Peptides and related molecules that bind to TALL-1
JOP20140087B1 (en) 2013-03-13 2021-08-17 Amgen Inc Proteins specific for baff and b7rp1 and uses thereof
US9458246B2 (en) 2013-03-13 2016-10-04 Amgen Inc. Proteins specific for BAFF and B7RP1

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449170A1 (en) * 1990-03-30 1991-10-02 BEHRINGWERKE Aktiengesellschaft Cellular binding protein with affinity for human type 18 papilloma virus regulatory region

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449170A1 (en) * 1990-03-30 1991-10-02 BEHRINGWERKE Aktiengesellschaft Cellular binding protein with affinity for human type 18 papilloma virus regulatory region

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GALERA ET AL.: "c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin", PROC. NATL ACAD. SCI., vol. 91, no. 20, 27 September 1994 (1994-09-27), pages 9372 - 9376 *
OLGIVIE ET AL.: "Sequence divergence of a TFIIIA-type zinc finger protein from fish ovarian tissue", NUCLEIC ACIDS RES., vol. 21, no. 17, pages 4152 *
REUTER ET AL.: "Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180", J. VIROLOGY, vol. 65, no. 10, pages 5564 - 5568 *

Cited By (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790941B2 (en) 1994-01-18 2004-09-14 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
USRE42211E1 (en) 1994-08-20 2011-03-08 Gendaq, Limited Relating to binding proteins for recognition of DNA
USRE39229E1 (en) 1994-08-20 2006-08-08 Gendaq Limited Binding proteins for recognition of DNA
USRE45795E1 (en) 1994-08-20 2015-11-10 Gendaq, Ltd. Binding proteins for recognition of DNA
USRE45721E1 (en) 1994-08-20 2015-10-06 Gendaq, Ltd. Relating to binding proteins for recognition of DNA
USRE42150E1 (en) 1994-08-20 2011-02-15 Gendaq, Limited Binding proteins for recognition of DNA
US7759059B2 (en) 1997-05-23 2010-07-20 Gendaq Limited, C/O Brobeck Hale And Dorr Nucleic acid binding proteins
US6866997B1 (en) 1997-05-23 2005-03-15 Gendaq Limited Nucleic acid binding proteins
US8617807B2 (en) 1997-05-23 2013-12-31 Gendaq Limited Nucleic acid binding proteins
US7241574B2 (en) 1997-05-23 2007-07-10 Gendaq Ltd. Nucleic acid binding proteins
US6746838B1 (en) 1997-05-23 2004-06-08 Gendaq Limited Nucleic acid binding proteins
WO1999021991A1 (en) * 1997-10-29 1999-05-06 Shanghai Second Medical University Bmzf12: a zinc finger gene cloned from bone marrow
US7928195B2 (en) 1998-03-02 2011-04-19 Massachusetts Institute Of Technology Poly zinc finger proteins with improved linkers
US6479626B1 (en) 1998-03-02 2002-11-12 Massachusetts Institute Of Technology Poly zinc finger proteins with improved linkers
US7595376B2 (en) 1998-03-02 2009-09-29 Massachusetts Institute Of Technology Poly zinc finger proteins with improved linkers
US7153949B2 (en) 1998-03-02 2006-12-26 Massachusetts Institute Of Technology Nucleic acid encoding poly-zinc finger proteins with improved linkers
WO1999046293A1 (en) * 1998-03-12 1999-09-16 Shanghai Second Medical University A zinc finger protein derived from hematopoietic cells
US6977154B1 (en) 1998-03-17 2005-12-20 Gendaq Limited Nucleic acid binding proteins
US6733970B2 (en) 1998-11-09 2004-05-11 Gendaq Limited Screening system for zinc finger polypeptides for a desired binding ability
US7163824B2 (en) 1999-01-12 2007-01-16 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7177766B2 (en) 1999-01-12 2007-02-13 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6607882B1 (en) 1999-01-12 2003-08-19 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7220719B2 (en) 1999-01-12 2007-05-22 Sangamo Biosciences, Inc. Modulation of endogenous gene expression in cells
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US6785613B2 (en) 1999-01-12 2004-08-31 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US7788044B2 (en) 1999-01-12 2010-08-31 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US7985887B2 (en) 1999-01-12 2011-07-26 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6824978B1 (en) 1999-01-12 2004-11-30 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US8268618B2 (en) 1999-01-12 2012-09-18 Sangamo Biosciences, Inc. Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
US6933113B2 (en) 1999-01-12 2005-08-23 Sangamo Biosciences, Inc. Modulation of endogenous gene expression in cells
US9491934B2 (en) 1999-01-12 2016-11-15 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6979539B2 (en) 1999-01-12 2005-12-27 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US7585849B2 (en) 1999-03-24 2009-09-08 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US8383766B2 (en) 1999-03-24 2013-02-26 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US8524874B2 (en) 1999-03-24 2013-09-03 Sangamo Biosciences Position dependent recognition of GNN nucleotide triplets by zinc fingers
US7235354B2 (en) 1999-09-14 2007-06-26 Sangamo Biosciences, Inc. Functional genomics using zinc finger proteins
US6777185B2 (en) 1999-09-14 2004-08-17 Sangamo Biosciences, Inc. Functional genomics using zinc finger proteins
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6503717B2 (en) 1999-12-06 2003-01-07 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US7943553B2 (en) 1999-12-06 2011-05-17 Sangamo Biosciences, Inc. Randomized libraries of zinc finger proteins
US7491531B2 (en) 1999-12-06 2009-02-17 Sangamo Biosciences, Inc. Randomized libraries of zinc finger proteins
US7851216B2 (en) 2000-01-24 2010-12-14 Gendaq, Ltd. Methods and compositions for linking binding domains in nucleic acid binding proteins
WO2001074866A1 (en) * 2000-03-02 2001-10-11 Biowindow Gene Development Inc. Shanghai A novel polypeptide-human zinc finger protein 72 and the polynucleotide encoding said polypeptide
WO2001074868A1 (en) * 2000-03-07 2001-10-11 Biowindow Gene Development Inc. Shanghai A novel polypeptide-human zinc finger protein 10 and the polynucleotide encoding said polypeptide
WO2001066580A1 (en) * 2000-03-07 2001-09-13 Biowindow Gene Development Inc. Shanghai A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it
WO2001074993A2 (en) * 2000-03-10 2001-10-11 Shanghai Biowindow Gene Development Inc. A novel polypeptide - human zinc finger protein 17 and the polynucleotide encoding said polypeptide
WO2001066583A1 (en) * 2000-03-10 2001-09-13 Shanghai Biowindow Gene Development Inc. A new polypeptide - human zinc finger protein 14 and the polynucleotide encoding it
WO2001066582A1 (en) * 2000-03-10 2001-09-13 Shanghai Biowindow Gene Development Inc. A NEW POLYPEPTIDE-HUMAN ZINC FINGER PROTEIN 27 AND THE POLYNUCLEOTIDE ENCODING It
WO2001074993A3 (en) * 2000-03-10 2002-11-28 Shanghai Biowindow Gene Dev A novel polypeptide - human zinc finger protein 17 and the polynucleotide encoding said polypeptide
WO2001074865A1 (en) * 2000-03-15 2001-10-11 Shanghai Biowindow Gene Development Inc. A novel polypeptide - human zinc finger protein 10 and the polynucleotide encoding said polypeptide
WO2001068690A1 (en) * 2000-03-15 2001-09-20 Shanghai Biowindow Gene Development Inc. A new polypeptide-human zinc finger protein 15 and the polynucleotide encoding it
WO2001072803A1 (en) * 2000-03-28 2001-10-04 Shanghai Biowindow Gene Development Inc. A new polypeptide- human zinc finger protein 15 and the polynucleotide encoding it
WO2001074882A1 (en) * 2000-03-28 2001-10-11 Shanghai Biowindow Gene Development Inc. A novel polypeptide-human zinc finger protein 49 and the polynucleotide encoding said polypeptide
WO2001094397A1 (en) * 2000-06-07 2001-12-13 Shanghai Biowindow Gene Development Inc. A novel polypeptide-zinc finger protein 79.46 and the polynucleotide encoding said polypeptide
WO2002004500A1 (en) * 2000-06-19 2002-01-17 Biowindow Gene Development Inc. Shanghai A new polypeptide- human zinc finger protein fpm315-17 and the polynucleotide encoding it
WO2002004502A1 (en) * 2000-06-19 2002-01-17 Biowindow Gene Development Inc. Shanghai A NEW POLYPEPTIDE- MURINE ZINC FINGER PROTEIN (Zfp-1)16 AND THE POLYNUCLEOTIDE ENCODING IT
WO2002020600A1 (en) * 2000-06-28 2002-03-14 Shanghai Biowindow Gene Development Inc. A new polypeptide- human zinc finger protein 10.45 and the polynucleotide encoding it
WO2002010211A1 (en) * 2000-06-30 2002-02-07 Shanghai Biowindow Gene Development Inc. A new polypeptide- human zinc finger protein 12.98 and the polynucloetide encoding it
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US7560440B2 (en) 2000-12-07 2009-07-14 Sangamo Bioschiences, Inc. Regulation of angiogenesis with zinc finger proteins
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US8071564B2 (en) 2000-12-07 2011-12-06 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7605140B2 (en) 2000-12-07 2009-10-20 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US9234187B2 (en) 2001-01-22 2016-01-12 Sangamo Biosciences, Inc. Modified zinc finger binding proteins
US8680021B2 (en) 2001-01-22 2014-03-25 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7273923B2 (en) 2001-01-22 2007-09-25 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US9234188B2 (en) 2001-01-22 2016-01-12 Sangamo Biosciences, Inc. Modified zinc finger binding proteins
US9238803B2 (en) 2001-01-22 2016-01-19 Sangamo Biosciences, Inc. Modified zinc finger binding proteins
US7705139B2 (en) 2001-01-22 2010-04-27 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US10344271B2 (en) 2001-01-22 2019-07-09 Sangamo Therapeutics, Inc. Modified zinc finger binding proteins
US7262054B2 (en) 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7939327B2 (en) 2002-08-29 2011-05-10 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
US7361635B2 (en) 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes

Also Published As

Publication number Publication date
DE4435919C1 (en) 1995-12-07
EP0784680A1 (en) 1997-07-23
JPH10506789A (en) 1998-07-07

Similar Documents

Publication Publication Date Title
DE4435919C1 (en) DNA encoding zinc finger protein
DE3752360T2 (en) Human DNA for detection of retinoblastoma
EP0517024B1 (en) Tetravalent bispecific receptors, their preparation and use
DE69635899T2 (en) POLYPEPTIDE THAT SUPPRESSING DIFFERENTIATION
DE69435038T2 (en) ACTIVE RECEPTOR-SIMILAR KINASE (ALK), ASSOCIATED TO THE TGF RECEPTOR FAMILY AND / OR THE BMP RECEPTOR FAMILY
WO1995003328A2 (en) Melanoma-inhibiting protein
WO1997023611A2 (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
DE4415743C2 (en) Papillomaviruses, means for their detection and for the therapy of diseases caused by them
DE19526386C1 (en) Papillomaviruses, means for their detection and for the therapy of diseases caused by them
DE69728436T9 (en) LEPTINE PROTEIN FROM PIG, CODED NUCLEIC ACIDS AND USES THEREOF
DE69434090T2 (en) EPSILON SUB-UNIT OF THE GABA A-RECEPTOR
DE69836278T2 (en) ALL FORMS OF HUMAN STAT3
EP1007671B1 (en) Fanconi-gen ii
DE69838565T2 (en) Nucleic acids of CIITA genes
EP0941369B1 (en) Dna for evaluating the progression potential of cervical lesions
EP0941336A2 (en) Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
DE19613606C1 (en) Gene for hypertension present on chromosome 12p
DE69834951T2 (en) A family of genes with transformational activity
EP0972047A2 (en) Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
WO1993013205A1 (en) Neuroblastoma-associated regulator gene
WO1999053091A2 (en) Dna coding for gdnf, parts of said dna and gdnf variants
EP1214398B1 (en) Chimeric virus-like particles or chimeric capsomers from bpv
DE19812375C1 (en) Nucleic acid encoding tumor suppressor proteins, tumor suppressor proteins, processes for their preparation, antibodies against tumor suppressor proteins and use of these articles
Malzac et al. Chromosomal localization of the human and mouse histidine decarboxylase genes by in situ hybridization. Exclusion of the HDC gene from the Prader-Willi syndrome region
EP0858465A2 (en) Anti-tumoral protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT.BUL.17/96 UNDER INID(51)"IPC",REPLACE"A01K 38/17"BY"A61K 38/17"

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: US

Ref document number: 1997 836014

Date of ref document: 19970407

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1995935327

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995935327

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1995935327

Country of ref document: EP